The most aggressive and with the worst prognosis are the basal-like subtypes, also referred to as triple-negative breast cancers (TNBC), because more than 80% of these tumours are typically negative for ER, HER2 and progesterone receptor (PR); this phenotype makes TNBC hardly responsive to available and accessible therapies [5]. Here, PGR is linked to neoplasm.